Phase I/II trial of X-396 in patients (pts) with ALK plus non-small cell lung cancer (NSCLC): Correlation with plasma and tissue genotyping and response to therapy (tx)

被引：0
|
作者：
Horn, L. [1 ]
Wakelee, H. [2 ]
Blumenschein, G. [3 ]
Reckamp, K. [4 ]
Waqar, S. [5 ]
Carter, C. A. [6 ]
Gitlitz, B. J. [7 ]
Infante, J. R. [8 ]
Sanborn, R. E. [9 ]
Neal, J. [2 ]
Gockerman, J. P. [10 ]
Dukart, G. [11 ]
Harrow, K. [11 ]
Liang, C. [11 ]
Gibbons, J. J. [11 ]
Hernandez, J. [12 ]
Newman-Eerkes, T. [12 ]
Lim, L. [12 ]
Lovly, C. [1 ]
机构：
[1] Vanderbilt Ingram Canc Ctr, Thorac Oncol, Nashville, TN USA
[2] Stanford Univ, Med Ctr, Med Oncol, Stanford, CA 94305 USA
[3] Univ Texas MD Anderson Canc Ctr, Thorac Head & Neck Oncol, Houston, TX 77030 USA
[4] City Hope Natl Med Ctr, Dept Med Oncol, Duarte, CA USA
[5] Washington Univ, Sch Med, Div Oncol, St Louis, MO USA
[6] Natl Naval Med Ctr, Thorac Oncol, Bethesda, MD USA
[7] Univ Southern Calif, Norris Comprehens Canc Ctr, Dept Med, Los Angeles, CA USA
[8] Sarah Cannon Res Inst, Med Oncol, Nashville, TN USA
[9] Providence Portland Med Ctr, Thorac Oncol Program, Portland, OR USA
[10] Novella Clin, Oncol, Morristown, NC USA
[11] Xcovery Holding Co, Oncon, Palm Beach Gardens, FL USA
[12] Resolut Biosci, Clin Operat, Bellevue, WA USA
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1210PD
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Symptoms of Bone and Liver Metastases in Patients with ALK plus Non-Small Cell Lung Cancer (NSCLC)
    Guerin, Annie
    Sasane, Medha
    Nitulescu, Roy
    Zhang, Jie
    Culver, Kenneth W.
    Wu, Eric Q.
    Macalalad, Alexander R.
    Dalai, Anand
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S412 - S412
  • [42] A phase II trial of pemetrexed (P) plus carboplatin (C) in patients (pts) with advanced non-small-cell lung cancer (NSCLC).
    Koshy, S
    Herbst, RS
    Obasaju, CK
    Fossella, F
    Papadimitrakopoulou, V
    Pisters, KMW
    Blumenschein, G
    Peeples, BO
    Hong, WK
    Zinner, RG
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 634S - 634S
  • [43] A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC)
    Kim, Se Hyun
    Shim, Hyo Sup
    Cho, Jaeho
    Jeong, Jae Heon
    Kim, Sun Mi
    Hong, Yun Kyoung
    Sung, Ji Hee
    Ha, Sang-Jun
    Kim, Hye Ryun
    Chang, Hyun
    Kim, Joo Hang
    Tania, Crombet
    Cho, Byoung Chul
    LUNG CANCER, 2013, 79 (03) : 270 - 275
  • [44] A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC).
    Kim, Han Sang
    Cho, Byoung Chul
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [45] Radiation therapy of stage I and II non-small cell lung cancer (NSCLC)
    Zierhut, D
    Bettscheider, C
    Schubert, K
    van Kampen, M
    Wannenmacher, M
    LUNG CANCER, 2001, 34 : S39 - S43
  • [46] Brigatinib (BRG) in patients (pts) with crizotinib (CRZ)-refractory ALK plus non-small cell lung cancer (NSCLC) and brain metastases in the pivotal randomized phase 2 ALTA trial
    Ou, Sai-Hong Ignatius
    Tiseo, Marcella
    Camidge, D. Ross
    Ahn, Myung-Ju
    Huber, Rudolf M.
    Hochmair, Maximilian J.
    Kim, Sang-We
    West, Howard Jack
    Reckamp, Karen L.
    Molina, Julian R.
    Liu, Geoffrey
    Delmonte, Angelo
    Ramirez, Santiago Viteri
    Bearz, Alessandra
    Summers, Yvonne J.
    Reichmann, William
    Kerstein, David
    Gettinger, Scott N.
    Kim, Dong-Wan
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [47] Efficacy and safety of patupilone in non-small cell lung cancer (NSCLC):: A phase I/II trial.
    Sanchez, J. M.
    Mellemgaard, A.
    Perry, M.
    Zatloukal, P.
    Hamm, J.
    Belani, C. P.
    Kim, E.
    Felip, E.
    Berton, M.
    Johri, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 390S - 390S
  • [48] Phase II trial of imatinib (I) and docetaxel (D) in recurrent non-small cell lung cancer (NSCLC)
    Huang, C. H.
    Williamson, S.
    Van Veldhuizen, P. J.
    Hsueh, C. T.
    Smith, H.
    Mayo, M.
    Allen, A.
    Kelly, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [49] A phase II study of vorinostat (NSC 701852) in patients (pts) with relapsed non-small cell lung cancer (NSCLC)
    Traynor, A. M.
    Dubey, S.
    Eickhoff, J.
    Kolesar, J. M.
    Marcotte, S. M.
    Hammes, L. C.
    Hallahan, C. M.
    Moore, C. E.
    Zwiebel, J.
    Schiller, J. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [50] Phase I/II trial of patupilone once every 3 weeks in patients with non-small cell lung cancer (NSCLC)
    Osterlind, K
    Sánchez, J
    Zatloukai, P
    Hamm, J
    Belani, C
    Kim, E
    Felip, E
    Sklenar, I
    Berton, M
    Johri, A
    LUNG CANCER, 2005, 49 : S261 - S261
12345